Citations

Mayo Clinic

Showing 10 of 108572 citations.

Plasma biomarkers of Alzheimer´s disease in the continuum of dementia with Lewy bodies
Przybelski, Scott A. , Lesnick, Timothy G. , Gunter, Jeffrey L. , Jain, Manoj , Miyagawa, Toji , Forsberg, Leah K. , Fields, Julie A. , Savica, Rodolfo , Graff‐Radford, Jonathan , Graff‐Radford, Neill R. , Petersen, Ronald C. , Lowe, Val J. , Diaz‐Galvan, Patricia , Algeciras‐Schimnich, Alicia , Schwarz, Christopher G. , Senjem, Matthew L. , Jack, Clifford R. , Min, Hoon-Ki Paul , Ramanan, Vijay K. , Jones, David T. , Botha, Hugo , Louis, Erik K. St. , Knopman, David S. , Ferman, Tanis J. , Boeve, Bradley F. , Kantarci, Kejal

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.078097 Get It

AbstractBackgroundPatients with dementia with Lewy bodies (DLB) may have Alzheimer´s disease (AD) pathology. Plasma biomarkers of beta‐amyloid (Aβ), phosphorylated tau (pTau), and neurodegeneration are sensitive to AD neuropathologic changes in AD dementia. While these plasma biomarkers are well tested in the AD continuum, their performance for concomitant AD pathology in the DLB continuum is still unclear.MethodWe included patients with isolated REM sleep behavior disorder (iRBD; n = 15), with mild cognitive impairment with Lewy bodies (MCI‐LB; n = 37), and with DLB (n = 70) from the Mayo Clinic Alzheimer’s Disease Research Center. Cognitively unimpaired individuals (CU; n = 100) included from the Mayo Clinic Study of Aging were balanced on age and sex. A panel of plasma biomarkers of Aβ40, Aβ42, p‐tau181, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) measures was obtained. We calculated the ratio of plasma Aβ40/42. Lower Aβ40/42 indicates increased Aβ pathology. Plasma Aβ40, Aβ42, GFAP, and NfL were measured using the Simoa® Neurology 4‐Plex E Advantage kit and pTau‐181 was measured with the Simoa® pTau‐181 Advantage V2 kit. Both were run on a Quanterix HD‐X analyzer. AD imaging biomarkers were assessed on PET using Pittsburgh compound B (PiB) for Aβ and 18F‐Flortaucipir for tau.ResultHigher levels of plasma GFAP were observed in the MCI‐LB (p = 0.014) and DLB (p<0.001) groups compared to CU (Figure). DLB patients also showed higher levels of plasma pTau181 (p<0.001) and NfL (p<0.001). Higher amyloid and tau PET standardized uptake value ratio (SUVr) in the DLB continuum were associated with higher levels of plasma p‐tau181, NfL, and GFAP (p<0.001). After accounting for age, plasma Aβ40/42 did not correlate with amyloid or tau PET SUVr.ConclusionIn the DLB continuum, abnormal levels of GFAP in plasma can be detected as early as the prodromal stages of the disease. Plasma pTau181 reached abnormal levels in the DLB stage. Higher plasma GFAP, NfL, and p‐tau181 are associated with higher amyloid and tau PET SUVr in the DLB continuum. Plasma biomarkers have the potential to contribute to screening and early diagnosis in the DLB continuum, which has implications in designing new treatments.
Which common MRI research sequences need de‐facing before research data sharing?
Gunter, Jeffrey L. , Petersen, Ronald C. , Schwarz, Christopher G. , Kremers, Walter K. , Arani, Arvin , Reid, Robert I. , Senjem, Matthew L. , Cogswell, Petrice M. , Vemuri, Prashanthi , Kantarci, Kejal , Knopman, David S. , Jack, Clifford R.

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.077970 Get It

AbstractBackgroundWe have previously shown that 3D T1‐weighted and 3D T2‐FLAIR brain MRI can potentially be re‐identified using face recognition, but this has not been tested for other MRI sequences commonly used in imaging studies of aging and dementia. Here we compare match rates of automated face recognition to re‐identify 3D T1‐weighted, 3D T2‐FLAIR, 3D T2‐weighted, 2D Axial T2‐FLAIR, multi‐echo GRE (T2*), diffusion MRI, functional MRI, ASL, and T2* GRE images.MethodWe used a dataset of 182 Mayo Clinic participants each with MRI and face photographs. MRIs used Siemens and GE vendor‐product sequences similar to ADNI3 and ADNI4 protocols. We created face reconstructions (“basic”, with minimal preprocessing, and “advanced” that automatically filled missing face regions using a template) from each MRI sequence, and we trained a Microsoft Azure PersonGroup face recognition classifier to recognize these MRI‐based faces. We then queried the classifier with five face photographs for each participant, and we recorded how often the classifier chose the correct MRI as the top‐ranked match. For image types with match rates > = 10%, we then repeated the experiment after de‐facing each MRI with mri_reface, our leading software that replaces faces in each image (“re‐faces”) with an average face.ResultResults are presented in Table 1. 3D T2‐FLAIR, 3D T1‐weighted, and 3D T2‐weighted images were matched at 96‐98%, and mri_reface reduced all to 8%. Axial T2‐FLAIR and ME‐GRE were matched at 32‐45%, and mri_reface reduced both to 1%. T2*‐GRE matched at 10%, and mri_reface reduced this to 1%. ASL matched at 8%, while dMRI and fMRI matched at only 0‐2%.ConclusionAmong current‐generation vendor‐product sequences, we recommend that de‐facing be applied before research data sharing of T1‐weighted, T2‐weighted, T2‐FLAIR, T2*, and ME‐GRE images. Minimal match rates for current‐generation product fMRI, ASL, and fMRI images suggest that they present low risk of re‐identification and can be shared without de‐facing, but this conclusion should be re‐evaluated if they are acquired without fat‐suppression, with a larger field of view, or if newer developments reduce the current levels of artifacts and distortion around the face.
Fluid Biomarkers for Neurobehavioral Dysregulation in Former American Football Players
Amerongen, Suzan van , Bernick, Charles , Alosco, Michael L. , Palmisano, Joseph , Tuz‐Zahra, Fatima , Balcer, Laura J. , Blennow, Kaj , Iliff, Jeffrey J. , Zetterberg, Henrik , Peskind, Elaine R. , Reiman, Eric M. , Pulukuri, Surya Vamsi , Tripodis, Yorghos , Geda, Yonas E. , Wethe, Jennifer V. , Katz, Douglas I. , Mez, Jesse , Adler, Charles H. , Ashton, Nicholas J. , Li, Ge , Shenton, Martha E. , Cummings, Jeffrey L. , Stern, Robert A.

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.077858 Get It

AbstractBackgroundThe NINDS criteria define Traumatic Encephalopathy Syndrome (TES) as the clinical manifestation of the neuropathologically diagnosed chronic traumatic encephalopathy (CTE). The core clinical features of TES include both cognitive and neuropsychiatric symptoms, the latter termed neurobehavioral dysregulation (NBD). We explored potential biological correlates of NBD by investigating fluid biomarkers of neuronal damage, astrogliosis, phosphorylated tau (pTau), neuroinflammation, and catecholamines in former American football players.MethodOur cohort consisted of former professional (PRO) and college (COL) American football players from the DIAGNOSE CTE Research Project. NBD was measured by four subscales (i.e., explosivity, emotional dyscontrol, impulsivity, affective lability) and a total NBD score, derived by factor analysis of multiple self‐report neuropsychiatric measures. Plasma neurofilament light (NfL) and glial fibrillary acidic protein (GFAP), CSF total tau and pTau181/231/217, as well as CSF biomarkers related to neuroinflammation (IL‐6, CRP, TNF‐α, VEGF‐A), were measured with various well‐validated immunoassay methods. Catecholamines in CSF (dopamine, 3,4‐dihydroxyphenylacetic acid, 3,4‐dihydroxyphenylalanine, noradrenaline, 3,4‐dihydroxyphenylglycol) were measured with HPLC. Multivariate linear regression models assessed the relationships between biomarkers and NBD scales, adjusted for age, BMI, race, and APOE e4, including stratification by exposure group, i.e., PRO, COL.ResultDemographics and biomarker levels are displayed in Table 1. High levels of IL‐6 were significantly associated with higher scores of all NBD subscales, independent of exposure group. Other significant relationships included plasma NfL with emotional dyscontrol and impulsivity. Within the college group, CSF pTau181 was significantly associated with emotional dyscontrol and CSF noradrenaline with explosivity, emotional dyscontrol, impulsivity, and total NBD score. (Table 2 & Figure 1). IL‐6 models were repeated with measures of cognitive dysfunction (another core feature of TES) added as covariates; these analyses again found significant relationships between IL‐6 and NBD, irrespective of cognitive functioning.ConclusionWe observed specific fluid biomarkers related to NBD in former American football players. Of note were the associations between IL‐6 and all NBD subscales (and not with cognitive functioning), suggesting that neuroinflammation may be a specific component in the expression of NBD symptoms. Future studies will investigate how these neuroinflammatory processes are related to other biomarkers, level of RHI exposure, and neuropathology.
Flortaucipir tau PET in former American football players
Protas, Hillary , Luo, Ji , Alosco, Michael L. , Balcer, Laura J. , Bernick, Charles , Banks, Sarah J. , Coleman, Michael J. , Mariani, Megan, McKee, Ann C. , Palmisano, Joseph , Peskind, Elaine R. , Johnson, Keith A. , Reiman, Eric M. , Su, Yi , Chen, Kewei , Adler, Charles H. , Au, Rhoda , Barr, William , Dodick, David W. , Katz, Douglas I. , Marek, Kenneth , McClean, Michael D , Mez, Jesse , Daneshvar, Daniel H. , II, Robert W. Turner , Wethe, Jennifer V. , Rabinovici, Gil D. , Tripodis, Yorghos , Cummings, Jeffrey L. , Shenton, Martha E. , Stern, Robert A.

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.077855 Get It

AbstractBackgroundChronic traumatic encephalopathy (CTE) is a neurodegenerative disease thought to be caused, in part, by repetitive head impact (RHI) exposure and characterized by phosphorylated tau deposition with varying patterns in the cerebral cortex. Flortaucipir tau PET data from the DIAGNOSE CTE Research Project was examined to investigate tau PET patterns and its relation to RHI exposure in former professional and college American football players.MethodIn this study, 218 DIAGNOSE CTE participants, ages 45‐74, with flortaucipir PET were included; 104 were former National Football League players (PRO), 58 were former college football players (COL), and 56 had no history of contact sports, other exposure to RHI, or traumatic brain injury (UE). Regional flortaucipir uptake was quantified using established procedures for three previously defined statistical regions (superior frontal, left parietal, and medial temporal) and compared across the three groups. Association analyses were also performed to examine the relationship between flortaucipir uptake and exposure to RHI using the cumulative head impact index for linear acceleration g‐force (CHII‐G). The potential clinical utility of flortaucipir PET for CTE was also investigated by examining its ability to differentiate participants meeting criteria for traumatic encephalopathy syndrome (TES) and probable or possible level of certainty for CTE pathology from those who do not meet those criteria.ResultSignificantly higher flortaucipir uptake was observed in former football players than in participants without RHI exposure, controlling for age and race for the superior frontal region (Fig. 1A), left parietal, and medial temporal regions. Association between regional flortaucipir uptake and CHII‐G was only observed in the superior frontal region in former players (PRO+COL) 60 years and older (Fig. 1B) and no association was observed in the full PRO+COL group. Flortaucipir PET was not able to differentiate TES groups in former football players (Fig. 1C).ConclusionElevated flortaucipir uptake was observed in former American football players to a group of unexposed men. The association between flortaucipir uptake and exposure to RHI may require a long latent period to manifest. Further investigation of more sensitive tau PET tracers and quantification techniques is warranted to better characterize CTE related tau pathology.
Florbetapir amyloid PET in cognitively impaired former professional and college American football players
Trujillo‐Rodriguez, Diana , Alosco, Michael L. , Balcer, Laura J. , Bernick, Charles , Baucom, Zachary, Johnson, Keith A. , McKee, Ann C. , Palmisano, Joseph , Reiman, Eric M. , Stern, Robert A. , Tripodis, Yorghos , Pulukuri, Surya Vamsi , Adler, Charles H. , Marek, Kenneth , McClean, Michael D , Stein, Thor D. , Mez, Jesse , Cummings, Jeffrey L. , Shenton, Martha E.

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.077854 Get It

AbstractBackgroundRepetitive head impact (RHI) exposure from the routine play of American football increases the risk of later‐life cognitive impairment and dementia from the neurodegenerative disease, chronic traumatic encephalopathy (CTE). Although neuropathological studies of CTE have found comorbid neurodegenerative and other pathologies, neuritic Aβ plaques are infrequent, particularly in early stages. However, amyloid PET imaging has not been fully characterized in cognitively impaired former American football players.MethodIn this cross‐sectional, observational cohort study from the DIAGNOSE CTE Research Project, florbetapir PET mean cortical standard uptake value ratios (SUVR) and positivity (defined by average SUVR >1.10, indicative of moderate‐to‐frequent neuritic Aβ plaques), were analyzed in 119 former professional (PRO) National Football League players, 60 former college football players (COL), and 58 men unexposed (UE) to RHI who were cognitively asymptomatic. Former players were categorized into one of four diagnostic groups: cognitively normal (CN), subjective memory complaints (SMC), mild cognitive impairment (MCI), and dementia (DEM). All participants were 45‐74 yo. Multivariable linear and logistic regressions were conducted, with race, education, age, and APOE4 genotype included as covariates. A priori power calculations demonstrated adequate power to detect significant findingsResultNo differences between the three exposure groups in average florbetapir SUVR or proportion of elevated florbetapir uptake were found. Pairwise group comparisons resulted in no differences in average SUVR between PRO and COL (‐0.01, 95% CI [‐0.033, 0.025], p = 0.95), PRO and UE (0.02, 95% CI [‐0.010, 0.029], p = 0.41), and COL and UE (0.02, 95% CI [0.0004, 0.039], p = 0.36). Analysis of covariance resulted in no differences among diagnostic groups (F = 0.94, p = 0.43). Neither years of playing football nor measures of cognition and daily functioning showed significant associations with florbetapir SUVR.ConclusionFormer professional and college American football players with cognitive impairment and dementia did not have elevated florbetapir amyloid PET compared to a group of men without RHI exposure. Their rates of florbetapir positivity in the football players were lower than expected for a group of men this age. These findings suggest that cognitive impairment in former elite football players may not be due to Alzheimer’s disease pathology.
Non‐imaging measures to predict variability in white matter changes relevant to VCID
Raghavan, Sheelakumari , Przybelski, Scott A. , Lesnick, Timothy G. , Fought, Angela J. , Gebre, Robel K , Vassilaki, Maria , Petersen, Ron, Graff‐Radford, Jonathan , Reid, Robert I. , Algeciras‐Schimnich, Alicia , Machulda, Mary M. , Knopman, David S. , Jack, Clifford R. , Vemuri, Prashanthi

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.077200 Get It

AbstractBackgroundSmall vessel disease (SVD) is a common vascular contributor to cognitive impairment and dementia. In this work, we evaluated and compared non‐imaging measures that can predict variability in SVD related white matter (WM) damage in a population‐based sample.MethodWe identified 752 participants in the population‐based sample of Mayo Clinic Study of Aging (≥50 years of age), who had at least 2 diffusion tensor imaging (DTI) scans and white matter hyperintensity (WMH) assessments along with baseline demographics, systemic vascular health, lifestyle, motor impairment, behavioral symptoms, and plasma markers (Summarized in Figure 1). We computed the WM markers of SVD: fractional anisotropy of genu of the corpus callosum (Genu‐FA) representative of early WM changes, WMH representative of late WM changes, and Vascular WM score (combination of Genu‐FA and WMH). Using all available data, we fit linear mixed effect models and evaluated predictors of WM markers by considering each category of features independently (with demographics) as well as by combining all categories of featuresResultPlasma, gait, systemic vascular, and life‐style measures were significant predictors of all three WM markers of SVD (Figure 2). The predictors of early and late WM slightly differed such that there were no additional significant contributions from behavioral and plasma measures to Genu‐FA. In the final composite models shown in Table 1, higher gait speed, lower number of cardiovascular and metabolic conditions (CMC) and lower Unified Parkinson’s disease rating scale scores were associated with better Genu‐FA whereas higher CMC, Beck Anxiety Inventory scores (BAI), and glial acidic protein (GFAP) levels were associated with higher burden of WMH.ConclusionOur observations evaluated the non‐imaging markers of greater WM damage that are relevant to vascular contributions to cognitive impairment to dementia (VCID). We found that in addition to higher vascular risk, worse plasma GFAP, gait measures, and BAI scores were predictors of greater WM damage. Some non‐imaging markers were more associated with early WM changes and others with late WM changes.
NODDI May Be More Sensitive to Neurodegenerative Changes Than Structural MRI
Gebre, Robel K , Przybelski, Scott A. , Raghavan, Sheelakumari , Lesnick, Timothy G. , Lowe, Val J. , Petersen, Ronald C. , Graff‐Radford, Jonathan, Yu, Xi, Reid, Robert I. , Machulda, Mary M. , Knopman, David S. , Kantarci, Kejal , Graff‐Radford, Jonathan , Jack, Clifford R. , Vemuri, Prashanthi

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.076509 Get It

AbstractBackgroundNeurite orientation dispersion and density imaging (NODDI) measures from diffusion MRI provide information about tissue microstructure. Our goal was to compare the sensitivity of NODDI to structural MRI (sMRI) in capturing neurodegenerative changes in the gray matter due to aging and dementia.MethodWe included 815 participants [644 cognitively unimpaired (CU), 103 MCI, 68 AD] from the Mayo Clinic Study of Aging (MCSA) and Mayo ADRC with sMRI and multi‐shell diffusion MRI. We assessed gray matter volumes scaled by head size and cortical thicknesses from sMRI and neurite density index (NDI) and isotropic volume fraction (ISOVF) from NODDI. Pairwise Spearman correlations were calculated between imaging measures and Tau‐PET SUVRs in Braak I‐II, III‐IV, and V‐VI regions of interest (ROI) in participants ≥ 60 years. Separate multivariable linear regression models were fit for the prediction of brain age using sMRI and NODDI in 515 CU participants. The predicted age gaps were calculated as chronological age minus predicted age in the remaining participants. We compared age gaps computed by sMRI and NODDI using disease surrogates (APOE4 genotype, AD pathologies via PET, WMH via FLAIR‐MRI, vascular risk, cognition via MMSE).ResultBraak ROIs, sMRI, and NODDI measures were correlated. The correlations between ISOVF and Tau‐PET SUVRs were stronger than correlations between NDI, volume, and thickness and Tau‐PET SUVR (Fig.1). MMSE was more associated with ISOVF than Tau‐PET and other imaging measures. The sMRI regression models had a higher mean absolute error (MAE) of 4.13 years than NODDI models with an MAE of 4.02 years. The NODDI model better predicted age gap separation between CU, MCI, and AD compared to the sMRI model (Fig.2). The NODDI predicted age gap showed stronger correlations with global amyloid‐PET SUVR, meta‐ROI Tau‐PET SUVR, CMC, APOE4, and MMSE (Fig. 3).ConclusionNODDI, especially ISOVF, had stronger correlations with MMSE and Tau‐PET SUVRs across all Braak ROIs. The brain age prediction model trained using NODDI was more sensitive in detecting neurodegeneration changes than sMRI based on associations with disease surrogates. Our work suggests that NODDI in gray matter may be a more sensitive surrogate of neurodegeneration compared to sMRI.
Prediction of Global Cognition Trajectories with Medial Temporal Brain Stiffness in Aging and Alzheimer’s Disease
Pavuluri, KowsalyaDevi , Murphy, Matthew C. , Huston, John , Ehman, Richard L. , Manduca, Armando , Vemuri, Prashanthi , Jack, Clifford R. , Senjem, Matthew L.

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.075279 Get It

AbstractBackgroundCognitive decline with aging and neurodegeneration is caused by various neurobiological processes at molecular, cellular, and organ levels. Advanced imaging techniques that detect tissue microstructural alterations may predict cognitive decline earlier than atrophy measures. Tissue‐level mechanical properties are thought to primarily reflect the rigidity and tension of extracellular matrix‐cytoskeleton matrix (https://doi.org/10.1038/s41586‐019‐1516‐5) and can be measured noninvasively by Magnetic Resonance Elastography (MRE) (https://doi.org/10.1126/science.7569924). These properties are sensitive to pathophysiological processes that characterize neurological disease including dementias. This study examines the role of medial temporal lobe stiffness in predicting global cognitive decline in participants along the Alzheimer’s disease spectrum.MethodSeventy‐five participants underwent MRE, MRI, amyloid PET imaging, and cognitive assessments with informed consent, and the study was approved by the Mayo Clinic IRB. MRE stiffness maps were calculated by neural network inversion, and medial temporal (MT) stiffness extracted (https://doi.org/10.1002/mrm.29226https://doi.org/10.1016/j.nicl.2023.103328). White matter hyperintensity (WMH) load, average cortical thickness of AD signature regions, PiB‐PET standardized uptake ratio (PiB‐SUVr), and global cognition z‐scores were each computed (https://doi.org/10.1016/j.neurobiolaging.2020.09.005). Linear mixed effect models were used to assess the effects of MT‐stiffness and its interaction with follow‐up time on global cognition. The additional effects of cortical thickness, WMH, and PiB‐SUVr, and their interactions with cognition follow‐up time were evaluated.ResultTable 1 summarizes results from three mixed effect models. MT‐stiffness and its interaction with time were significant predictors in models 1 (MT‐stiffness only) and 2 (MT‐stiffness+cortical thickness). In model 3 (MT‐stiffness+cortical thickness+PiB‐ratio+WMH), MT‐stiffness alone did not reach significance (P= 0.058), but its interaction with time was a significant predictor. Fig.1 shows global cognition z‐scores with age. Figs. 2A,2B, and 2C show global cognition prediction trajectories. These results suggest that softer MT‐stiffness predicts faster cognitive decline. MT‐stiffness was a significant predictor of cognitive score even when controlling for other biomarkers such as cortical thickness, PiB‐SUVr, and WMH. These results indicate that stiffness measurements can add predictive value regarding cognitive decline in addition to atrophy and amyloidosis.ConclusionBrain mechanical alterations capture microstructural changes that may aid in understanding disease progression and provide information about future cognitive decline in elderly participants along the Alzheimer’s disease continuum.
Effects of de‐facing T1 MRI, FLAIR MRI, Amyloid PET, and Tau PET scans on imaging‐clinical correlations analyses
Weigand, Stephen D. , Prakaashana, Carl M., Lowe, Val J. , Gunter, Jeffrey L. , Petersen, Ronald C. , Schwarz, Christopher G. , Kremers, Walter K. , Senjem, Matthew L. , Kantarci, Kejal , Vemuri, Prashanthi , Knopman, David S. , Jack, Clifford R.

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.073792 Get It

AbstractBackgroundAutomated face recognition can potentially re‐identify de‐identified research brain MRI, PET, and CT, and direct differences of brain measurements from original and de‐faced images are statistically significant but very minor, i.e. below scan‐rescan differences. Their effects on analyses correlating brain imaging biomarkers with clinical variables remain unknown.MethodWe sampled 3 age‐and‐sex‐matched groups (CU, MCI, and clinical AD) from Mayo Clinic aging studies, each with 61 participants with same‐visit 3D T1‐weighted and 3D T2‐FLAIR MRI, PiB amyloid PET, and Flortaucipir tau PET (total n = 183). We automatically measured hippocampal volume, PIB global SUVR, and tau temporal meta‐ROI SUVR using a) our in‐house pipeline with SPM12, MCALT, and ANTs, and b) FreeSurfer 7.3.2 (PETSurfer), and we measured voxels associated with clinical group separation using SPM12. We also measured WMH from FLAIR using a) our in‐house pipeline, b) Lesion Segmentation Tool (LST), and c) FreeSurfer’s Samseg. For each measurement, we calculated pair‐wise group separation AUC values and Spearman’s rho with age and CDR‐SOB. We then de‐faced all PET and MRI using mri_reface, our top‐performing automated de‐facing software that replaces imaged faces with an average face (“re‐facing”), and we repeated all measurements and analyses with de‐faced images. We then compared the magnitudes of clinical correlations with original images and those of de‐faced images.ResultAnalyses of original and de‐faced images had very high agreement. Only 2/55 paired comparisons were significant (Tables 1‐2): FreeSurfer‐measured global PIB SUVR from de‐faced images was more correlated with age (rho 0.003 vs ‐0.227, p = 0.046), and Mayo‐measured WMH volume from original images was more correlated with CDR‐SOB (rho 0.321 vs 0.308, p = 0.020). Another comparison‐pair tested p = 0.041 for an AUC change +0.008, which we consider not practically meaningful. All others had p>0.05. In voxel‐based analyses of CU vs AD participants, all comparisons were qualitatively similar between original and de‐faced variants (Figure 1).ConclusionDe‐facing PET and MRI using mri_reface did not significantly affect 53/55 correlations between imaging and clinical variables; of the two affected, one became stronger with re‐faced images. Stronger correlations with clinical variables may be explained by de‐facing’s standardizing face voxels and artifacts that irrelevantly affect brain segmentations.
Default mode network sub‐systems connectivity in atypical Alzheimer’s disease
Sintini, Irene , Radford, Jonathan Graff, Martin, Peter R. , Gunter, Jeffrey L. , Petersen, Ronald C. , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Corriveau‐Lecavalier, Nick , Jones, David T. , Singh, Neha Atulkumar , Botha, Hugo , Machulda, Mary M. , Schwarz, Christopher G. , Jack, Clifford R.

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.073446 Get It

AbstractBackgroundDisruption of default mode network (DMN) connectivity is common in Alzheimer’s disease. We investigated cross‐sectional and one‐year longitudinal changes in DMN sub‐systems in atypical clinical presentations of AD, in relation to age and tau.MethodSixty‐four amyloid‐positive atypical AD (Aty‐AD) patients diagnosed with posterior cortical atrophy (n = 35) or logopenic progressive aphasia (n = 29) were recruited by the Neurodegenerative Research Group. Patients underwent structural and resting‐state functional MRI, and [18F]flortaucipir PET at baseline and one‐year follow‐up. 140 amyloid‐negative cognitively unimpaired (CU) individuals from the Mayo Clinic Study of Aging were included as controls. Global tau SUVR was calculated in a meta‐ROI including parietal, temporal, and occipital regions. DMN connectivity was calculated in native space for posterior (pDMN), ventral (vDMN), anterior ventral (avDMN) and anterior dorsal (adDMN) DMN sub‐systems using the dual regression method. A global measure of DMN connectivity, the Network Failure Quotient (NFQ), was calculated as (vDMN_to_pDMN+ adDMN_to_pDMN)/(pDMN+vDMN). Linear mixed‐effects models were computed for each DMN connectivity measure, including diagnosis (Aty‐AD, CU), age, time and their interaction, and a per‐person random effect. SPM paired t‐tests were run to compare baseline and follow‐up images in Aty‐AD and CU separately. Linear mixed‐effect models were run in the Aty‐AD cohort only to investigate the effect of global baseline tau SUVR on each DMN connectivity measure.ResultMixed‐effects models showed evidence of lower cross‐sectional pDMN and higher adDMN connectivity in Aty‐AD relative to CU, with no significant time effects (Fig. 1). While connectivity in all DMN sub‐systems declined with age in CU, connectivity was higher in older Aty‐AD patients relative to younger, particularly in vDMN and pDMN. A similar trend was observed for NFQ, which was significantly higher in Aty‐AD, with a negative age effect (Fig. 1). In Aty‐AD, voxel‐based analyses showed moderate evidence of decline in vDMN connectivity and increase in avDMN connectivity over time (Fig. 2). Greater baseline global tau SUVR was associated with lower vDMN connectivity, cross‐sectionally and longitudinally (Fig. 3).ConclusionDMN connectivity was altered in Aty‐AD, with strongest alterations in younger patients. The vDMN declined over time, suggesting a shift in DMN connectivity with disease progression that was likely related to tau pathology.